Clinical Trial Update: Drug Interaction Between Ritonavir And Sitaxsentan [Phase 1]

View source ↗

Summary

Phase 1 trial assessing the drug interaction between ritonavir and sitaxsentan for pulmonary arterial hypertension has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Norvir (ritonavir)
• Thelin (sitaxentan)

Snippet

Sponsor: Pfizer | Conditions: Pulmonary Arterial Hypertension | Phase 1 | Status: WITHDRAWN